J&J Confide OTC HIV test approved, phone counseling to be monitored in Phase IV survey.
This article was originally published in The Tan Sheet
Executive Summary
J&J CONFIDE TELEPHONE COUNSELING TO BE MONITORED IN POSTMARKET SURVEY following the introduction of the OTC home HIV test, the company said. On May 14, Confide became the first home HIV testing service to gain FDA approval. The product will be marketed by J&J's Direct Access Diagnostics subsidiary.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning